These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2309633)

  • 1. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial vulnerability and electrophysiology determined in patients with and without paroxysmal atrial fibrillation.
    Kühlkamp V; Haasis R; Seipel L
    Pacing Clin Electrophysiol; 1992 Jan; 15(1):71-80. PubMed ID: 1371003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
    Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
    Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D; Ishibashi K; Sakai R; Inoue M; Omori I; Asayama J; Nakagawa M
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation.
    Prakash A; Saksena S; Hill M; Krol RB; Munsif AN; Giorgberidze I; Mathew P; Mehra R
    J Am Coll Cardiol; 1997 Apr; 29(5):1007-14. PubMed ID: 9120152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
    Kakugawa H; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kanemoto M; Matsuzaki M
    Circ J; 2003 Oct; 67(10):810-5. PubMed ID: 14578610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Z Kardiol; 1988 Sep; 77(9):595-9. PubMed ID: 3195178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P; Manz M; Schütz R; Lüderitz B
    Z Kardiol; 1989 Oct; 78(10):654-60. PubMed ID: 2686252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.
    Ohmura K; Kobayashi Y; Miyauchi Y; Endoh Y; Atarashi H; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2003 Mar; 26(3):692-702. PubMed ID: 12698669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D; D'Hautefeuille B; Scheck F; Mycinsky C; Pruvost P; Peraudeau P
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation.
    Kumagai K; Matsuo K; Ono M; Yamanouchi Y; Moroe K; Hamasaki N; Arakawa K
    Pacing Clin Electrophysiol; 1993 Feb; 16(2):309-16. PubMed ID: 7680460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cibenzoline transforms random re-entry into ordered re-entry in the atria.
    Brugada J; Gürsoy S; Brugada P; Atié J; Guiraudon G; Andries E
    Eur Heart J; 1993 Feb; 14(2):267-72. PubMed ID: 8449204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.